January 20, 2008
A Phase II Clinical Trial Of Sorafenib In Androgen-Independent Prostate Cancer
UroToday.com- In the January 1, 2008 issue of Clinical Cancer Research, Dr. Dahut and colleagues report a Phase II trial of Sorafenib in androgen-independent prostate cancer (AICaP). Sorafenib is an oral, multikinase inhibitor targeting Raf kinase, vascular endothelial growth factor receptor, platelet-derived growth factor receptor, c-kit, and
From A Phase II Clinical Trial Of Sorafenib In Androgen-Independent Prostate Cancer
Posted by Gary at 05:28 PM
Beyond The Abstract - Cholesterol-Lowering Drugs And Prostate Cancer Risk: A Population-Based Case-Control Study
UroToday.com - This is a large case-control study estimating prostate cancer incidence among users of statins and other cholesterol-lowering drugs in a study population of 24,723 case-control pairs. It is a register-based study including all newly diagnosed prostate cancer cases in Finland during 1995-2002 and individually matched
Posted by Ryan at 01:49 PM
Docetaxel Plus Prednisone Or Mitoxantrone Plus Prednisone For Advanced Prostate Cancer: Updated Survival In The TAX ...
UroToday.com- The TAX 327 study was reported in 2004 and evaluated patients with hormone-refractory prostate cancer (HRPC) in three treatment arms; docetaxel 75mg/m2 every 3 weeks (D3P), docetaxel 30mg/ m2 weekly (D1P), or mitoxantrone 12 m2 every 3 weeks (MP), each with prednisone 5mg twice
Posted by Ryan at 01:48 PM
Prostate cancer therapy draws medical tourists
PUERTO VALLARTA, Mexico Some weekends, more than a dozen American men wait at beachfront hotels, anxious for their turns in the treatment room at a small private hospital here. They are medical tourists with prostate cancer. And they are queued up for the latest therapy one advertised with pictures of couples strolling on the beach and pitched as way to treat the disease while preserving
From Prostate cancer therapy draws medical tourists
Posted by Greg at 09:27 AM
January 19, 2008
Prostate Cancer Information from TAP
Prostate.com is a prostate cancer resource from TAP Pharmaceuticals that provides information about diseases of the prostate and treatment options for men ...
From Prostate Cancer Information from TAP
Posted by Russell at 02:30 PM
Prostate cancer treatment draws fire
U.S. medical tourists are headed to Latin American health clinics to receive a controversial prostate cancer treatment not approved in the United States.High-intensity focused ultrasound, or HIFU therapy, uses isolated bursts of high-intensity sound waves that produce temperatures 80-90 degrees Celsius to attack cancerous tissues in the prostate through a rectal probe, The New York Times
From Prostate cancer treatment draws fire
Posted by Murray at 12:41 PM
Enlarged prostate: An inevitable, treatable condition
D EAR SAVVY SENIOR: I have been seeing advertisements on television about older men who have erratic bathroom problems because of prostate enlargement. What can you tell me about this and can it lead to prostate cancer? - Gotta Go Joe
From Enlarged prostate: An inevitable, treatable condition
Posted by Jim at 10:49 AM
Robotic Prostate Cancer Surgery Performed On Two Brothers, Just Hours Apart
"We are blessed to have each other to depend on. If you have to go through something bad like cancer, you're glad to have a friend to go through it with," said one of two brothers from Savannah, Georgia recovering from robotic prostate cancer surgery. The two siblings flew to The Mount Sinai Medical Center in New York to have lifesaving surgery on the same day this week. Dr. David B. Samadi,
From Robotic Prostate Cancer Surgery Performed On Two Brothers, Just Hours Apart
Posted by Ryan at 10:48 AM
